文献速递其他结缔组织病

成纤维细胞线粒体钙超载通过mtDNA泄漏与cGAS-STING激活驱动系统性硬化症皮肤纤维化

Fibroblast Mitochondrial Ca2+ Overload Drives Skin Fibrosis via Mitochondrial DNA Leakage and Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Activation in Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2026-06-23

该研究在50例SSc患者和20例健康对照中检测血浆mtDNA,并分析5例dcSSc与5例HC真皮成纤维细胞的线粒体结构与功能。发现SSc中mtDNA升高且与FVC负相关、与mRSS及IL-6、TGF-β正相关;Ca2+-mtDNA-cGAS-STING轴驱动成纤维细胞活化,H-151在博来霉素小鼠模型中减轻皮肤纤维化。

要点

  • SSc患者血浆mtDNA显著高于HC,且与mRSS、IL-6、TGF-β正相关,与FVC负相关。
  • SSc成纤维细胞MCU与VDAC1升高,促线粒体Ca2+超载、mPTP开放、VDAC1寡聚化及胞质mtDNA积聚。
  • 阻断mPTP或VDAC1减少胞质mtDNA,STING抑制剂H-151抑制促纤维化标志并减轻小鼠皮肤纤维化。

核心结论

  • Ca2+-mtDNA-cGAS-STING轴驱动SSc成纤维细胞活化与皮肤纤维化,是有前景的治疗靶点。

研究设计与样本

  • 血浆mtDNA用qPCR在50例SSc患者与20例健康对照中定量。
  • 原代真皮成纤维细胞来自5例弥漫性皮肤型SSc与5例健康对照,每组n=5,分析线粒体结构、功能及RNA测序。
  • 用Ca2+调节剂与抑制剂检测mPTP开放与VDAC1寡聚化,并用siRNA敲低STING验证。
  • STING抑制剂H-151在体外及博来霉素诱导皮肤纤维化模型中评估,每组6只小鼠。

主要发现

  • SSc患者血浆mtDNA水平显著高于健康对照。
  • 血浆mtDNA与用力肺活量负相关(r=-0.436,P<0.01),与改良Rodnan皮肤评分正相关(r=0.807,P<0.001)。
  • 血浆mtDNA与白细胞介素-6正相关(r=0.667,P<0.001),与转化生长因子β正相关(r=0.678,P<0.001)。
  • SSc成纤维细胞呈现异常线粒体形态与功能障碍。
  • MCU与VDAC1升高促进线粒体Ca2+超载、mPTP开放、VDAC1寡聚化及胞质mtDNA积聚,激活cGAS-STING通路并触发促纤维化反应。

关键数值与推荐

  • 药理学阻断mPTP或VDAC1可减少胞质mtDNA。
  • H-151抑制SSc成纤维细胞促纤维化标志物。
  • H-151减轻博来霉素处理小鼠真皮增厚与胶原沉积。

临床怎么用

  • 血浆mtDNA与mRSS、IL-6、TGF-β正相关并与FVC负相关,提示其可能作为SSc皮肤与肺受累的候选生物标志物。
  • 靶向mPTP、VDAC1或STING的干预在临床前模型中减少促纤维化反应,支持进一步转化研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the clinical relevance of mitochondrial DNA (mtDNA) in systemic sclerosis (SSc) and elucidate the mechanism by which mtDNA leakage drives fibroblast activation. METHODS: Plasma mtDNA was quantified by quantitative polymerase chain reaction in 50 patients with SSc and 20 healthy controls (HCs). Primary dermal fibroblasts from five patients with diffuse cutaneous SSc and five HCs (n = 5 per group) were analyzed for mitochondrial structure, function, and RNA sequencing profiling. The opening of the mitochondrial permeability transition pore (mPTP) and oligomerization of VDAC1 were examined with Ca2+ modulators and inhibitors. Stimulator of interferon genes (STING) knockdown using small interfering RNA was performed for validation. The STING inhibitor H-151 was evaluated in vitro and in a bleomycin-induced skin fibrosis model (n = 6 mice per group). RESULTS: Plasma mtDNA levels were significantly higher in patients with SSc than in HCs, negatively correlating with forced vital capacity (r = -0.436, P < 0.01) and positively correlating with the modified Rodnan skin score (r = 0.807, P < 0.001), interleukin-6 (r = 0.667, P < 0.001), and transforming growth factor β (r = 0.678, P < 0.001). SSc fibroblasts exhibited abnormal mitochondrial morphology and dysfunction. Increased MCU and VDAC1 levels promoted mitochondrial Ca2+ overload, mPTP opening, VDAC1 oligomerization, and cytosolic mtDNA accumulation, which activated the cyclic GMP-AMP synthase (cGAS)-STING pathway and triggered profibrotic responses. Pharmacologic blockade of mPTP or VDAC1 reduced cytosolic mtDNA, whereas H-151 suppressed profibrotic markers in SSc fibroblasts and attenuated dermal thickening and collagen deposition in bleomycin-treated mice. CONCLUSION: The Ca2+-mtDNA-cGAS-STING axis drives fibroblast activation and skin fibrosis in SSc, representing a promising therapeutic target.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zhang X, Wang Y, Huang H, et al. Fibroblast Mitochondrial Ca2+ Overload Drives Skin Fibrosis via Mitochondrial DNA Leakage and Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Activation in Systemic Sclerosis. Arthritis Rheumatol. 2026. PMID: 42334244. doi:10.1002/art.70261

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。